Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Liver MR With Gadobenate Dimeglumine vs Gadoxetate Disodium for Hepatic Metastases
NCT04973007Phase 4Terminated
- Sponsor
- University of Colorado Denver
- Start
- Jun 2021
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of gadobenate dimeglumine in liver metastases, sponsored by University of Colorado Denver. Started Jun 2021; status: terminated.
02
Drugs
gadobenate dimeglumine
03
Conditions
liver metastases
Beyond the preview
Go deeper on NCT04973007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04973007.